약물전달학
- 건국대학교
- 신하연
페이스북
트위터
카카오톡
네이버밴드
링크복사
-
- 주제분류
- 의약학 >약학 >약학
-
- 강의학기
- 2017년 2학기
-
- 조회수
- 17,554
-
- 강의계획서
- 강의계획서
This course will provide students with a basic understanding of principles and applications of controlled drug delivery systems. To this end, it will focus on topics including physicochemical and biological barriers, drug delivery pathways, metabolism, drug formulation, pharmacokinetic and pharmacodynamic issues. It will expand the coverage to reflect latest updates and advances in materials for delivery vehicles, drug delivery approaches, and therapeutics.
- 수강안내 및 수강신청
- ※ 수강확인증 발급을 위해서는 수강신청이 필요합니다
Physiological, Biochemical, andChemical Barriers to Oral Drug Delivery
차시별 강의
| 1. | |
Factors that Impact the Developability of Drug Candidates | ※교수자 및 학교(기관)의 사정으로 인해 서비스 중지된 차시입니다. | |
| 2. | |
Physiological, Biochemical, andChemical Barriers to Oral Drug Delivery | Introduction 1. Physiological Barriers to Drug Delivery 2. Biochemical Barriers to Drug Delivery |
 |
| 3. | |
Physiological, Biochemical, and Chemical Barriers to Oral Drug Delivery | 2. Biochemical Barriers to Drug Delivery 3. Chemical Barriers to Drug Delivery 4. Drug Modifications to Enhance Transport Across Biological Barriers |
|
| 4. | |
PhysicochemicalProperties, Formulation, and Drug Delivery | 1. Physicochemical Properties 2. Formulations |
|
| 5. | |
PhysicochemicalProperties, Formulation, and Drug Delivery | 3. Drug Delivery 1. Target Bioavailability |
|
| 6. | |
Targeted Bioavailability: A Fresh Look at Pharmacokinetic and Pharmacodynamic Issues in Drug Discovery and Development | 1. Target Bioavailability 2. Drug Delivery Trends and Targets Related to PK and PD 3. PK？PD in Drug Discovery and Development 4. Source of Variability of Drug Response |
|
| 7. | |
Targeted Bioavailability :A Fresh Look at Pharmacokinetic and Pharmacodynamic Issues in Drug Discovery and Development | 4. Source of Variability of Drug Response 5. Recent Development and Issues of Bio- Analytical Methodology 6.Mechanistic PK？PD Models |
|
| 8. | |
The Role of Transporters in Drug Delivery and Excretion | 1. Drug Transport in Absorption and Excretion 2. ABC (ATP-Binding Cassette) Transporter Family |
|
| 9. | |
The Role of Transporters in Drug Delivery and Excretion | 3. SlC (Solute Carrier) Transporter Family | |
| 10. | |
Intracellular Deliveryand Disposition of Small-Molecular Weight Drugs | 1. The Relationship between the Intracellular Distribution of a Drug and its Activity 2. The Relationship between the Intracellular Distribution of a Drug and its Pharmacokinetic Properties 3. Overview of Approaches to Study Intracellular Drug Disposition 4. The Accumulation of Drugs in Mitochondria, Lysosomes, and Nuclei |
|
| 11. | |
Intellectual Property and Regulatory Issues inDrug Delivery Research | 1. Pharmaceutical Patents 2. Statutory Requirements for Obtaining a Patent 3. Patent Procurement Strategies |
|
| 12. | |
Intellectual Property and Regulatory Issues inDrug Delivery Research | 4. Regulatory Regime 5. FDA Market Exclusivities 6. Regulatory and Patent Law Linkage |
|
| 13. | |
Presystemic and First-Pass Metabolism | 1. Hepatic First-Pass Metabolism | |
| 14. | |
Pulmonary DrugDelivery: PharmaceuticalChemistry and Aerosol Technology | 1. Aerosol Technology 2. Disease Therapy |
|
| 15. | |
Pulmonary DrugDelivery: PharmaceuticalChemistry and Aerosol Technology | 1. Aerosol Technology 2. Disease Therapy |
|
|
Pulmonary DrugDelivery: PharmaceuticalChemistry and Aerosol Technology | 2. Disease Therapy 3. Formulation Variables 4. Future Developments |
|
|
|
Transdermal Delivery of Drugs Using Patchesand Patchless Delivery Systems | 1. Transdermal Patch Delivery Systems 2. Patchless Transdermal Drug Delivery Systems |
|
|
|
Transdermal Delivery of Drugs Using Patchesand Patchless DeliverySystems, Prodrug Approaches toDrug Delivery | 2. Patchless Transdermal Drug Delivery Systems 3. Recent Advances in Transdermal Drug Delivery 1. Basic Concepts: Definition and Applications |
|
|
|
Prodrug Approaches to Drug Delivery | 1. Basic Concepts: Definition and Applications 2. Prodrug Design Considerations |
|
|
|
Nanoparticles as DrugDelivery Vehicles | 1. General DDV Properties 2. Organic DDVs 3. Inorganic DDVs: Metal- and Silica ]Based Systems |
|
|
|
Nanoparticles as DrugDelivery Vehicles | 1. General DDV Properties 2. Organic DDVs 3. Inorganic DDVs: Metal- and Silica ]Based Systems |
|
연관 자료
